Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes.

Annals of the New York Academy of Sciences - 1 Aug 2006

Benn Diana E, Richardson Anne Louise, Marsh Deborah J, Robinson Bruce G

Abstract excerpt

Genetic understanding of pheochromocytoma (PHEO) and paraganglioma (PGL) syndromes has recently expanded with the identification of the involvement of the mitochondrial complex II peptides, namely the succinate dehydrogenase subunit B (SDHB), subunit C (SDHC), and subunit D (SDHD). In patients with PHEO and/or PGL genetic testing for germline mutations in SDHD and SDHB has been recommended, in addition to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Gland Neoplasms
Share to SDHC gene
Share to SDHD gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Germ-Line Mutation

Share to Paraganglioma

Share to Pheochromocytoma

Source

Identifiers

PMID: 17102077
DOI: 10.1196/annals.1353.011

Genes

SDHB
SDHD
RET
SDHC
VHL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes.PMID 17102077Read ↗

Genetic testing for pheochromocytoma-associated syndromes.Semantic proximity Read ↗

Genetic testing in pheochromocytoma: increasing importance for clinical decision making.Semantic proximity Read ↗

Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paragangliomaSemantic proximity Read ↗

Genetic testing in pheochromocytoma or functional paraganglioma.Semantic proximity Read ↗

Genetic stratification of inherited and sporadic phaeochromocytoma and paraganglioma: implications for precision medicineSemantic proximity Read ↗

Pheochromocytoma and paraganglioma syndromes: genetics and management updateSemantic proximity Read ↗

Hereditary pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Back to Biochemistry: Evaluation for and Prognostic Significance of SDH Mutations in Paragangliomas and Pheochromocytomas.Semantic proximity Read ↗

Back to Biochemistry: Evaluation for and Prognostic Significance of SDH Mutations in Paragangliomas and Pheochromocytomas.Semantic proximity Read ↗

Pathology and genetics of phaeochromocytoma and paragangliomaSemantic proximity Read ↗

Pheochromocytoma: an update on genetics and management.Semantic proximity Read ↗

Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.